Premium
[P3–024]: STEADY‐STATE CLINICAL PHARMACOKINETICS DEMONSTRATING ONCE‐WEEKLY CORPLEX TM DONEPEZIL TRANSDERMAL SYSTEM AS A THERAPEUTIC ALTERNATIVE TO DAILY ORAL ARICEPT
Author(s) -
Singh Parminder “Bobby”,
Miller Vaeling
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.1837
Subject(s) - donepezil , tolerability , transdermal , medicine , pharmacokinetics , pharmacology , adverse effect , oral administration , transdermal patch , crossover study , disease , dementia , alternative medicine , pathology , placebo
lack of feedback (25% vs. 13%). Conclusions:These data suggest that research satisfaction is high for participants/partners. Efforts to improve research satisfaction engagement and retention should highlight altruism, as well as creating strong relationships between staff and participants and partners, providing detailed feedback and being mindful of the time commitment and burden on study partners.